nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—SLC6A4—attention deficit hyperactivity disorder	0.92	1	CbGaD
Desvenlafaxine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0212	0.425	CbGeAlD
Desvenlafaxine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.0112	0.226	CbGeAlD
Desvenlafaxine—Venlafaxine—SLC6A3—attention deficit hyperactivity disorder	0.00384	0.572	CrCbGaD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—TPH2—attention deficit hyperactivity disorder	0.00345	0.146	CbGpPWpGaD
Desvenlafaxine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00298	0.0598	CbGeAlD
Desvenlafaxine—Venlafaxine—SLC6A4—attention deficit hyperactivity disorder	0.00287	0.428	CrCbGaD
Desvenlafaxine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00262	0.0526	CbGeAlD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—MAOA—attention deficit hyperactivity disorder	0.00208	0.0881	CbGpPWpGaD
Desvenlafaxine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.00197	0.0395	CbGeAlD
Desvenlafaxine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.00162	0.0324	CbGeAlD
Desvenlafaxine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.00156	0.0312	CbGeAlD
Desvenlafaxine—SLC6A4—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00147	0.0623	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00144	0.0613	CbGpPWpGaD
Desvenlafaxine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.00142	0.0286	CbGeAlD
Desvenlafaxine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.00137	0.0275	CbGeAlD
Desvenlafaxine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00137	0.058	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00126	0.0536	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00124	0.0527	CbGpPWpGaD
Desvenlafaxine—SLC6A4—brain—attention deficit hyperactivity disorder	0.00124	0.0248	CbGeAlD
Desvenlafaxine—SLC6A2—brain—attention deficit hyperactivity disorder	0.00109	0.0218	CbGeAlD
Desvenlafaxine—SLC6A4—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.00105	0.0444	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.00101	0.0429	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.000947	0.0402	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.0009	0.0382	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—attention deficit hyperactivity disorder	0.000809	0.0343	CbGpPWpGaD
Desvenlafaxine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000792	0.0159	CbGeAlD
Desvenlafaxine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000762	0.0153	CbGeAlD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000484	0.0205	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000414	0.0176	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000371	0.0157	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000356	0.0151	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000338	0.0143	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000331	0.014	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000329	0.014	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000311	0.0132	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.0003	0.0127	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00027	0.0115	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000267	0.0113	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000261	0.0111	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000254	0.0108	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000249	0.0106	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000246	0.0104	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00024	0.0102	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000236	0.01	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000235	0.00996	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000203	0.00861	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000168	0.00715	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000107	0.00456	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000101	0.00429	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	8.77e-05	0.00372	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.56e-05	0.00363	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.41e-05	0.00229	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.37e-05	0.00228	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.33e-05	0.00226	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.21e-05	0.000938	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.53e-05	0.000648	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.53e-05	0.000648	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.5e-05	0.000637	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.4e-05	0.000592	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.22e-05	0.000518	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.16e-05	0.000493	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	9.24e-06	0.000392	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	9.18e-06	0.00039	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.96e-06	0.000168	CbGpPWpGaD
